FDA inspection
Pfizer Clinical Research Unit, Hopital Erasme: FDA inspection ending Apr 12, 2019
FDA inspection 1088933 · No Action Indicated (NAI) · Anderlecht
Key facts
| Inspection ID | 1088933 |
|---|---|
| Firm | Pfizer Clinical Research Unit, Hopital Erasme |
| FEI number | 3007000232 |
| Address | Route De Lennik 808 |
| City | Anderlecht |
| Country | Belgium |
| Fiscal year | 2019 |
| Inspection end date | Apr 12, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data